drugset / Trial / NCT00195429

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

NCT00195429

Phase 4 Completed 47 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates two different immunosuppression drug regimens in patients with a recent kidney transplant. Patients initially received a regimen of Sirolimus, Tacrolimus and Prednisone and then randomized to discontinue either Tacrolimus or Prednisone.

Timeline

Start
2005-08
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified
Subject Tacrolimus Small molecule
Background Sirolimus Small molecule